Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists Unravel the Drama of a Decade of Cancer Research

03.08.2004


Reviewing the last 10 years of cancer research much as they might the production of a play complete with cast members, opening acts and an ever-twisting plot, two of the most cited names in science say that one of the most promising roles that newly discovered cancer genes may perform is in early detection, which likely will be as important as new treatments.

In an editorial review that is the centerpiece of Nature Medicine’s 10th anniversary August issue, Johns Hopkins Kimmel Cancer Center scientists Bert Vogelstein, M.D., and Kenneth Kinzler, Ph.D., used a lengthy Broadway metaphor to suggest that the conquest of cancer is a drama that has lots more acts to come, some of them destined to refocus large parts of the national research effort.

"The best chance of managing these diseases in the next few decades relies on taking advantage of the genes we now know lie at the heart of the process," says Vogelstein, who is the world’s most influential scientist according to citation rankings by the Institute of Scientific Information. "Cancer already is curable when it’s caught early. New methods of detecting cancers, although less dramatic and not as popular, offer very promising approaches for limiting cancer deaths in the future."



In the past, the Hopkins scientists argue that the lack of better "scripts" including key gene characters hindered drug development and early diagnostic efforts. With a refined cast of characters, more researchers may steer their efforts to better diagnostic and therapeutic strategies, which may have a greater impact on cancer death rates.

In their review, Vogelstein and Kinzler describe the progress in understanding cancer and the roles of nearly 100 genes that have been definitively linked to cancer. The opening act introduces three kinds of genes that regulate cancer growth pathways. Oncogenes, when altered, get stuck in active duty, much as a stuck accelerator in a car. In opposite roles, tumor suppressor genes act as malfunctioning brakes. Finally, faulty stability genes act like bad auto mechanics, failing to repair mistakes made in the DNA code during replication or exposure to mutating agents. Genes that control blood supply to a tumor are cast in important supporting roles.

The central plot involves the cell growth pathways that these genes control--discoveries that demonstrate how each gene affects a cascade of protein production that is necessary for cancer development. Remarkably, the majority of these genes, which vary considerably in different cancers, converge on a relatively small number of similar pathways that direct cancer growth, providing a common story line.

"Researchers know many of the genes involved in cancer development and are learning how to put the entire cast together, and we are beginning to understand the best ways to apply gene discoveries to help patients," says Kinzler. "The last decade of gene discovery now sets the stage for this sequel which will include new methods for early detection as well as targeted therapeutics."

In addition to developing more sophisticated tools for early detection of tumors, Vogelstein and Kinzler say other areas of future research should include better models for testing targeted therapies and investigating the functions of novel genes auditioning for leading roles in the cancer process.

Vogelstein and Kinzler have been studying the genetics of cancer for more than 20 years and have made pivotal discoveries of genes and pathways that lead to cancer, including those involving p53, APC, mismatch repair and Gli. Vogelstein is the Clayton Professor of Oncology at the Johns Hopkins Kimmel Cancer Center and Investigator, Howard Hughes Medical Institute. Kinzler is Professor of Oncology and co-directs the Molecular Genetics Laboratory with Vogelstein at the Kimmel Cancer Center. Vogelstein, B. and Kinzler, K. W., Cancer Genes and the Pathways They Control, Nat Med 10(8), August 2004.

| newswise
Further information:
http://www.hopkinskimmelcancercenter.org

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>